Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113121462B reveals a metal-free, azide-free route for 5-trifluoromethyl-1,2,3-triazoles. Enhance supply chain reliability and reduce manufacturing costs significantly.
Patent CN113045503B details a novel Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN116253692A reveals a metal-free route for trifluoromethyl 1,2,4-triazines, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN116253692A reveals a metal-free route for trifluoromethyl 1,2,4-triazines. Discover cost-effective manufacturing and scalable supply chain advantages for pharmaceutical intermediates.
Patent CN113880724A reveals a cost-effective Knoevenagel-based route for 3-(2-aminophenyl)-2-acrylate, offering high purity and scalable manufacturing for global API supply chains.
Patent CN114920707B reveals a novel iodine-promoted cyclization using DMF as a carbon source, offering significant cost reduction in API manufacturing and streamlined supply chains.
Patent CN111423381A reveals a mild palladium-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering cost-effective API intermediate manufacturing with high yields.
Novel Pd-catalyzed one-pot method for high-purity trifluoromethyl chromone quinoline intermediates. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN115353511A details a novel Pd-catalyzed multicomponent synthesis for carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and scalable routes.
Patent CN115286553B details a novel nickel-catalyzed route for indole synthesis offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Novel palladium-catalyzed method reduces cost and improves supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN112694430B details a novel Pd-catalyzed bis-carbonylation route for pyrrol-2-one scaffolds, offering high yields and operational simplicity for API manufacturing.
Novel Pd-catalyzed one-pot method for trifluoromethyl chromone quinoline. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN110724094A reveals a novel metal-free route for quinoline synthesis using diazocarbonyl compounds, offering significant cost reduction and simplified purification for API manufacturing.
Patent CN111978265B reveals a novel FeCl3-catalyzed route for high-purity triazole intermediates, offering significant cost reduction and scalable manufacturing for global pharma supply chains.
Patent CN115260080B reveals efficient Pd-catalyzed route. Offers cost reduction and supply reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN115246807B details efficient thioester synthesis. Offers supply chain stability and cost reduction for pharmaceutical intermediates manufacturing globally.
Patent CN112480015B reveals a Pd-catalyzed one-pot method for quinazolinones, offering cost-effective routes for API manufacturing and reliable supply chain solutions.
Novel chiral phosphoric acid catalysis for indoline pyrroles. High ee, mild conditions. Reliable supplier for anticancer intermediates.
Patent CN111747879B details a large-scale synthesis of Erexib avoiding unstable intermediates. Discover cost-effective manufacturing and supply chain advantages.